Relay Therapeutics Inc (RLAY) earnings · rev $15.4M
These earnings events as JSON? API free 100/dayRelay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
This RLAY earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported RLAY revenue for 2025-12-31 was $15.4M. Net income was -$276.5M. Revenue was up 53.4% from 2024-12-31 to 2025-12-31. RLAY currently screens at market cap $3.39B.
When the next RLAY 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 53.4% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full RLAY research stays on the stock page; the tape stays on the quote page.
RLAY earnings FAQ
What are RLAY's latest revenue and net income?
Latest cached Relay Therapeutics Inc (RLAY) revenue for Dec 31, 2025 was $15.4M. Net income was -$276.5M. Statements: https://lician.com/financials/rlay
What is RLAY's latest diluted EPS?
Latest cached Relay Therapeutics Inc (RLAY) diluted EPS for Dec 31, 2025 was -$1.61.
What period does the latest RLAY earnings print cover?
The latest cached Relay Therapeutics Inc (RLAY) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did RLAY revenue change from the prior cached period?
Cached Relay Therapeutics Inc (RLAY) revenue was up 53.4% from $10.0M (Dec 31, 2024) to $15.4M (Dec 31, 2025). Statements: https://lician.com/financials/rlay
Where are RLAY earnings listed?
Cached earnings facts for Relay Therapeutics Inc (RLAY) are listed at https://lician.com/earnings/rlay. Statements: https://lician.com/financials/rlay
Not investment advice.